Clinical Trial Update: A DB Randomized Study of R1 and R2 WaterJel / AloeVera Jell in Prevention of Radiation Dermatitis in Breast Cancer

View source ↗

Summary

A randomized study evaluating Water-Jel Aloe Vera Gel (R1/R2) for prevention of radiation dermatitis in breast cancer patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Radiation Dermatitis

Drugs mentioned

• Water-Jel Aloe Vera Gel (R1/R2)

Snippet

Sponsor: Water-Jel | Conditions: Breast Cancer, Radiation Dermatitis | Status: TERMINATED